Outpatient Management After Spontaneous Coronary Artery Dissection
After a SCAD event, lifelong aspirin (75-162 mg daily) combined with beta-blockers forms the cornerstone of outpatient medical therapy, with clopidogrel 75 mg daily added for 3-12 months based on bleeding risk, particularly in premenopausal women who may experience menorrhagia. 1
Antiplatelet Therapy Strategy
Core Regimen
- Aspirin 75-162 mg daily indefinitely is the foundation of therapy 1
- Beta-blockers are essential and have demonstrated a 61% reduction in recurrent SCAD risk (HR 0.39; 95% CI 0.19-0.78) 1
Dual Antiplatelet Therapy (DAPT) Duration
The approach differs based on whether revascularization occurred:
If stented during acute event:
If managed conservatively (most cases):
- Add clopidogrel 75 mg daily for 3-12 months to aspirin 1, 3
- Critical caveat: Shorten DAPT duration or use aspirin alone in premenopausal women experiencing menorrhagia, as bleeding risk outweighs theoretical benefit 1
- The rationale for DAPT is that intimal disruption creates prothrombotic potential, and antiplatelet therapy may reduce false lumen thrombus burden 1
Blood Pressure Management
Aggressive hypertension control is mandatory - hypertension increases recurrent SCAD risk 2.3-fold (HR 2.28; 95% CI 1.14-4.55) 1. Target optimal blood pressure control to prevent recurrence.
Lipid Management
Statins are NOT routinely indicated unless there are other specific indications 1. SCAD is a non-atherosclerotic process, distinguishing it fundamentally from typical coronary artery disease. Early concerns about statins potentially increasing SCAD recurrence were not confirmed in subsequent data, but they remain unnecessary in the absence of:
- Documented atherosclerotic disease
- Familial hyperlipidemia
- Other compelling indications
Symptom Management
Angina Control
If persistent chest pain occurs:
- Optimize beta-blocker dosing first
- Add calcium channel blockers if needed 1
- Consider nitrates for symptom relief
- Ranolazine may be considered for refractory angina 1
Important distinction: Evaluate whether symptoms represent true ischemia versus anxiety/chest wall pain, which is common post-SCAD.
Screening for Associated Conditions
Screen all SCAD patients for fibromuscular dysplasia (FMD) - present in 72% of SCAD cases 3. Perform:
- Renal artery imaging (CT/MR angiography)
- Iliac artery assessment
- Cerebrovascular imaging 3
This is critical because FMD represents systemic arteriopathy requiring its own management.
Activity and Cardiac Rehabilitation
Gradual return to activity is recommended, but avoid:
- High-intensity isometric exercises
- Activities causing extreme physical stress
- Valsalva-inducing activities
Start with low-to-moderate intensity aerobic exercise, monitoring for symptoms. The goal is maintaining cardiovascular fitness without triggering recurrence through excessive wall stress.
Monitoring and Follow-Up
Recurrence Risk
- Recurrent SCAD occurs in 11-17% of patients at median 2.8-3.6 years 4
- 10-year estimated recurrence risk approaches 29-30% 4
- Recurrence typically affects different coronary segments (77-100% of cases) 4
Risk Factor for Recurrence
Severe coronary tortuosity is the only validated predictor of recurrent SCAD 4. If present on initial angiography, maintain heightened vigilance.
Follow-Up Schedule
- Close monitoring in first year when recurrence risk is highest
- Educate patients on symptom recognition
- Low threshold for evaluation of new chest pain
- Regular assessment for depression and anxiety, which are common post-SCAD
Hormonal Considerations
Avoid exogenous estrogen therapy given the strong female predominance and hormonal associations with SCAD 5. For contraception, consider:
- Progesterone-only methods
- Non-hormonal options
- Individualized discussion of risks/benefits
What NOT to Do
Critical pitfalls to avoid:
- Do not treat SCAD like atherosclerotic ACS - the pathophysiology is fundamentally different
- Do not prescribe statins reflexively "because it's an MI" 1
- Do not continue DAPT indefinitely in women with significant menorrhagia - bleeding risk exceeds benefit 1
- Do not assume chest pain represents recurrence without evaluation - anxiety and chest wall pain are common
- Do not recommend high-intensity exercise programs without careful assessment
Psychosocial Support
Address the significant psychological impact - depression and anxiety are prevalent post-SCAD. Consider:
- Formal psychological evaluation
- Support groups (SCAD-specific when available)
- Treatment of mood disorders as indicated
This comprehensive but conservative approach reflects that 70-97% of SCAD lesions heal spontaneously 1, supporting the medical management strategy while remaining vigilant for the minority who experience recurrence.